SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
---|---|---|---|---|---|---|---|---|
08-Sep-23 4:00 PM View: | 180 Life Sciences Corp. (ATNF) | 04-Sep-23 | Grant | 21,455 | $1.36 | $29,178.80 | 726% 2.95K to 24.41K | |
02-Nov-22 5:01 PM View: | 180 Life Sciences Corp. (ATNF) | 31-Oct-22 | Grant | 30,702 | -- | -- | 108% 28.37K to 59.07K | |
29-Jul-22 4:17 PM View: | 180 Life Sciences Corp. (ATNF) | 27-Jul-22 | Grant | 13,068 | -- | -- | 85% 15.3K to 28.37K | |
23-May-22 4:34 PM View: | 180 Life Sciences Corp. (ATNF) | 19-May-22 | Grant | 10,570 | $1.36 | $14,375.20 | 100% 0 to 10.57K | |
18-Jan-22 4:33 PM View: | 180 Life Sciences Corp. (ATNF) | 14-Jan-22 | Grant | 4,728 | $3.04 | $14,373.10 | 100% 0 to 4.73K | 10% |
04-Jan-22 4:05 PM View: | Merrimack Pharmaceuticals, ... (MACK) | 31-Dec-21 | Market Sale | 1,000 | $3.84 | $3,839.80 | (100%) 1.0K to 0 | (4%) |
19-Mar-15 7:33 PM View: | Allergan Inc. (AGN) | 17-Mar-15 | Disposition | 27,167 | -- | -- | (100%) 27.17K to 0 | |
08-May-14 7:20 PM View: | Allergan Inc. (AGN) | 06-May-14 | Grant | 1,249 | -- | -- | 5% 25.92K to 27.17K | |
02-May-13 9:08 PM View: | Allergan Inc. (AGN) | 30-Apr-13 | Grant | 3,102 | -- | -- | 14% 22.81K to 25.91K | |
26-Nov-12 6:27 PM View: | Allergan Inc. (AGN) | 21-Nov-12 | Option Exercise | 15,000 | $39.74 | $596,125.00 | 37% 40.8K to 55.8K | |
26-Nov-12 6:27 PM View: | Allergan Inc. (AGN) | 21-Nov-12 | Private Option Sale | 15,000 | $91.05 | $1,365,710.00 | (27%) 55.8K to 40.8K | (162%) |
26-Nov-12 6:27 PM View: | Allergan Inc. (AGN) | 21-Nov-12 | Private Sale | 18,000 | $91.05 | $1,638,850.00 | (44%) 40.8K to 22.8K | (162%) |
02-May-12 8:47 PM View: | Allergan Inc. (AGN) | 01-May-12 | Grant | 4,800 | -- | -- | 13% 36.0K to 40.8K | |
04-May-09 8:20 PM View: | Allergan Inc. (AGN) | 30-Apr-09 | Grant | 14,400 | -- | -- | 133% 10.8K to 25.2K | |
03-May-06 7:08 PM View: | Allergan Inc. (AGN) | 02-May-06 | Grant | 5,400 | -- | -- | 100% 5.4K to 10.8K |